Toggle navigation
Home
Search
Services
Blog
Contact
About
Studies of Monoclonal Antibodies (OVS) Ovarian Cancer
Moongkarndi, Primchanien
Duke University, Durham, NC, United States
Search grants from Primchanien Moongkarndi
Search grants from Duke University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Serological assays to predict Shigella vaccine efficacy
Automatic Bayesian Methods In Text Retrieval
Interactive intraoperative imaging with cone beam CT
Regulation of Energy Balance - Intestinal Mechanisms
Molecular Biology of Human Thrombospondin
Recently added grants:
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
Signaling pathways during hepatocarcinogenesis
Tumor-promoting liver injuries and mechanisms
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
5F05TW004687-02
Application #
2292826
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Project Start
1993-09-23
Project End
Budget Start
1993-09-23
Budget End
1994-03-22
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Duke University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Related projects
NIH 1993
F05 TW
Studies of Monoclonal Antibodies (OVS) Ovarian Cancer
Moongkarndi, Primchanien / Duke University
NIH 1992
F05 TW
Studies of Monoclonal Antibodies (OVS) Ovarian Cancer
Moongkarndi, Primchanien / Duke University
Comments
Be the first to comment on Primchanien Moongkarndi's grant